In Vivo Transcriptomics-Based Framework for Systematic Indication Expansion
Capturing the systemic effects of drugs in vivo remains a fundamental challenge for drug repurposing strategies. Here, we present an in vivo transcriptomics-based drug repurposing framework that profiles multi-organ RNA-seq from drug-treated rodents to model systemic drug responses and match tissue-specific drug signatures against a compendium of disease signatures for indication expansion. We…
We haven't written up this one. bioRxiv has the full story — the link below goes straight to it.
